12:00 AM
 | 
Feb 25, 2013
 |  BC Week In Review  |  Company News  |  Deals

Alexion deal

Alexion recommended shareholders reject an unsolicited mini-tender offer by investment firm TRC Capital Corp. to acquire up to 1.5 million shares, or about 0.77% of the company's common stock, for $90.50 per share. The price is...

Read the full 159 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >